Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Gastrointestinal Bleeding | Research

Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding

Authors: Mohsen Masoodi, Mohammad Sabzikarian, Nikta Masoodi, Saeed Farhadi, Gholam Reza Rezamand, Seidamir Pasha Tabaeian, Atefeh Talebi, Farimah Fayyaz

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Background/Aims

Upper gastrointestinal bleeding (UGIB) is a frequent medical issue. The primary risk factors for bleeding peptic ulcers are Helicobacter pylori infection and non-steroidal anti-inflammatory drugs. The association between acute gastric/duodenal ulcer and opium use has been previously proposed; however, there is no available data on endoscopic findings of patients with acute UGIB who use opium.

Materials and methods

In the present descriptive cross-sectional study, endoscopic data of 50 consecutive patients with oral opium use and 50 consecutive patients without any opium use who were admitted for UGIB were recorded. The size (5–10 mm, 11–20 mm, or more than 20 mm), number (single, double, or multiple), and location of the ulcers (esophagus, gastric corpus including the fundus and body, antrum, angulus, or duodenum) were examined by endoscopy in both groups.

Results

Three or more ulcers were observed in 46% and 16% of patients with oral opium use and without opium use, respectively (P-value = 0.001). The rate of giant ulcers (> 20 mm) was significantly higher in patients who used oral opium (40% vs. 12%; P-value = 0.007). Esophageal ulcers were also more common in oral opium users (30%) than non-users (8%) with UGIB (P-value = 0.01). Nevertheless, the location of the ulcers between the two groups generally was not statistically different.

Conclusions

This study has demonstrated that multiple, large peptic ulcers in GIB are potential complications of oral opium use. This could aid the needed modifications in the treatment protocol for these patients.
Literature
1.
go back to reference Masoodi M, Saberifiroozi M. Etiology and outcome of acute gastrointestinal bleeding in Iran: a review article. Middle East Journal of Digestive Diseases. 2012;4(4):193.PubMedPubMedCentral Masoodi M, Saberifiroozi M. Etiology and outcome of acute gastrointestinal bleeding in Iran: a review article. Middle East Journal of Digestive Diseases. 2012;4(4):193.PubMedPubMedCentral
3.
go back to reference Malfertheiner P, Schulz C, Peptic Ulcer. Chapter Closed? Digestive Diseases. 2020;38(2):112–6.CrossRef Malfertheiner P, Schulz C, Peptic Ulcer. Chapter Closed? Digestive Diseases. 2020;38(2):112–6.CrossRef
4.
go back to reference Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–93.PubMedCrossRef Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–93.PubMedCrossRef
5.
go back to reference Khamaysi I, Gralnek IM. Acute upper gastrointestinal bleeding (UGIB)–initial evaluation and management. Best Pract Res Clin Gastroenterol. 2013;27(5):633–8.PubMedCrossRef Khamaysi I, Gralnek IM. Acute upper gastrointestinal bleeding (UGIB)–initial evaluation and management. Best Pract Res Clin Gastroenterol. 2013;27(5):633–8.PubMedCrossRef
6.
go back to reference Sverdén E, Markar SR, Agreus L, Lagergren J. Acute upper gastrointestinal bleeding. BMJ. 2018;363. Sverdén E, Markar SR, Agreus L, Lagergren J. Acute upper gastrointestinal bleeding. BMJ. 2018;363.
7.
go back to reference Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80(5):1035–68.PubMedCrossRef Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80(5):1035–68.PubMedCrossRef
8.
go back to reference Boonpongmanee S, Fleischer DE, Pezzullo JC, Collier K, Mayoral W, Al-Kawas F, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004;59(7):788–94.PubMedCrossRef Boonpongmanee S, Fleischer DE, Pezzullo JC, Collier K, Mayoral W, Al-Kawas F, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004;59(7):788–94.PubMedCrossRef
9.
go back to reference Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008;67(3):422–9.PubMedCrossRef Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008;67(3):422–9.PubMedCrossRef
10.
go back to reference Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009;70(2):212–24.PubMedCrossRef Loperfido S, Baldo V, Piovesana E, Bellina L, Rossi K, Groppo M, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009;70(2):212–24.PubMedCrossRef
11.
go back to reference Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic Ulcer Disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13.PubMedCrossRef Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC. Systematic review of the epidemiology of complicated peptic Ulcer Disease: incidence, recurrence, risk factors and mortality. Digestion. 2011;84(2):102–13.PubMedCrossRef
12.
go back to reference Mahajan R, Gupta Y, Singh A, Dhiman P, Midha V, Kakkar C, et al. Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity. Intestinal Res. 2020;18(2):238.CrossRef Mahajan R, Gupta Y, Singh A, Dhiman P, Midha V, Kakkar C, et al. Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity. Intestinal Res. 2020;18(2):238.CrossRef
13.
go back to reference Salehi M, Sadeghi F, Shirvani JS, Shahandashti EF, Khafri S, Rajabnia R. Study on relationship between acute gastrointestinal disease and Helicobacter pylori infections. J Acute Disease. 2017;6(6):264.CrossRef Salehi M, Sadeghi F, Shirvani JS, Shahandashti EF, Khafri S, Rajabnia R. Study on relationship between acute gastrointestinal disease and Helicobacter pylori infections. J Acute Disease. 2017;6(6):264.CrossRef
14.
go back to reference Farahmand H, PourGholami M, Fathollah MS. Chronic extrahepatic bile duct dilatation: sonographic screening in the patients with opioid addiction. Korean J Radiol. 2007;8(3):212–5.PubMedPubMedCentralCrossRef Farahmand H, PourGholami M, Fathollah MS. Chronic extrahepatic bile duct dilatation: sonographic screening in the patients with opioid addiction. Korean J Radiol. 2007;8(3):212–5.PubMedPubMedCentralCrossRef
15.
go back to reference Cho CH, Wu KK, Wu S, Wong TM, So WH, Liu ES, et al. Morphine as a drug for stress ulcer prevention and healing in the stomach. Eur J Pharmacol. 2003;460(2–3):177–82.PubMedCrossRef Cho CH, Wu KK, Wu S, Wong TM, So WH, Liu ES, et al. Morphine as a drug for stress ulcer prevention and healing in the stomach. Eur J Pharmacol. 2003;460(2–3):177–82.PubMedCrossRef
16.
go back to reference Khansari M, Sohrabi M, Zamani F. The useage of opioids and their adverse effects in gastrointestinal practice: a review. Middle East Journal of Digestive Diseases. 2013;5(1):5.PubMedPubMedCentral Khansari M, Sohrabi M, Zamani F. The useage of opioids and their adverse effects in gastrointestinal practice: a review. Middle East Journal of Digestive Diseases. 2013;5(1):5.PubMedPubMedCentral
17.
go back to reference Penagini R, Allocca M, Cantu P, Mangano M, Savojardo D, Carmagnola S, et al. Relationship between motor function of the proximal stomach and transient lower oesophageal sphincter relaxation after morphine. Gut. 2004;53(9):1227–31.PubMedPubMedCentralCrossRef Penagini R, Allocca M, Cantu P, Mangano M, Savojardo D, Carmagnola S, et al. Relationship between motor function of the proximal stomach and transient lower oesophageal sphincter relaxation after morphine. Gut. 2004;53(9):1227–31.PubMedPubMedCentralCrossRef
18.
go back to reference Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. chapman and hall/CRC; 2017. Chow S-C, Shao J, Wang H, Lokhnygina Y. Sample size calculations in clinical research. chapman and hall/CRC; 2017.
19.
go back to reference Arkkila PE, Kokkola A, Seppälä K, Sipponen P. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol. 2007;42(6):695–701.PubMedCrossRef Arkkila PE, Kokkola A, Seppälä K, Sipponen P. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics. Scand J Gastroenterol. 2007;42(6):695–701.PubMedCrossRef
20.
go back to reference Brătucu MN, Prunoiu V-M, Strâmbu V, Brătucu E, Răvaş M-M, Simion L, et al. Unusual Complicated Gastric Ulcers Medicina. 2021;57(12):1345.PubMed Brătucu MN, Prunoiu V-M, Strâmbu V, Brătucu E, Răvaş M-M, Simion L, et al. Unusual Complicated Gastric Ulcers Medicina. 2021;57(12):1345.PubMed
21.
go back to reference Tahami AN, Khanjani N, Feyzabadi VY, Varzandeh M, Haghdoost A-A. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Arch Iran Med. 2014;17(1):0. Tahami AN, Khanjani N, Feyzabadi VY, Varzandeh M, Haghdoost A-A. Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Arch Iran Med. 2014;17(1):0.
22.
go back to reference Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.PubMedCrossRef Shakeri R, Malekzadeh R, Etemadi A, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, et al. Opium: an emerging risk factor for gastric adenocarcinoma. Int J Cancer. 2013;133(2):455–61.PubMedCrossRef
23.
go back to reference United Nation Office on Drugs and Crime (UNODC), World Drug Report 2019 (United Nations publication, Sales No. E. 19. XI. 8). United Nation Office on Drugs and Crime (UNODC), World Drug Report 2019 (United Nations publication, Sales No. E. 19. XI. 8).
24.
go back to reference Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Mojtabai R, Radgoodarzi R, et al. Alcohol use disorders in Iran: prevalence, symptoms, correlates, and comorbidity. Drug Alcohol Depend. 2017;176:48–54.PubMedCrossRef Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Mojtabai R, Radgoodarzi R, et al. Alcohol use disorders in Iran: prevalence, symptoms, correlates, and comorbidity. Drug Alcohol Depend. 2017;176:48–54.PubMedCrossRef
25.
go back to reference Joshi A, Falodia S, Kumar N, Solanki R. Small intestine strictures in opium addicts: an unrecognized cause of intestinal obstruction. Indian J Gastroenterol. 2018;37(2):169–73.PubMedCrossRef Joshi A, Falodia S, Kumar N, Solanki R. Small intestine strictures in opium addicts: an unrecognized cause of intestinal obstruction. Indian J Gastroenterol. 2018;37(2):169–73.PubMedCrossRef
26.
go back to reference Häuser W, Lachiheb H, Grandt D. [Colitis ulcerosa and opioid addiction]. Z Gastroenterol. 2002;40(5):299–303.PubMedCrossRef Häuser W, Lachiheb H, Grandt D. [Colitis ulcerosa and opioid addiction]. Z Gastroenterol. 2002;40(5):299–303.PubMedCrossRef
27.
go back to reference Gyires K, Fürst S, Farczádi E, Márton A. Morphine potentiates the gastroulcerogenic effect of indometacin in rats. Pharmacology. 1985;30(1):25–31.PubMedCrossRef Gyires K, Fürst S, Farczádi E, Márton A. Morphine potentiates the gastroulcerogenic effect of indometacin in rats. Pharmacology. 1985;30(1):25–31.PubMedCrossRef
28.
go back to reference Parmar NS, Tariq M, Ageel AM. Studies on the possible mechanism of morphine-induced potentiation of the gastroulcerogenic effect of indomethacin in rats. Arch Int Pharmacodyn Ther. 1987;289(1):149–60.PubMed Parmar NS, Tariq M, Ageel AM. Studies on the possible mechanism of morphine-induced potentiation of the gastroulcerogenic effect of indomethacin in rats. Arch Int Pharmacodyn Ther. 1987;289(1):149–60.PubMed
29.
go back to reference Tazi-Saad K, Chariot J, Vatier J, Del Tacca M, Rozé C. Antisecretory and anti-ulcer effects of morphine in rats after gastric mucosal aggression. Eur J Pharmacol. 1991;192(2):271–7.PubMedCrossRef Tazi-Saad K, Chariot J, Vatier J, Del Tacca M, Rozé C. Antisecretory and anti-ulcer effects of morphine in rats after gastric mucosal aggression. Eur J Pharmacol. 1991;192(2):271–7.PubMedCrossRef
30.
go back to reference Gyires K. Morphine inhibits the ethanol-induced gastric damage in rats. Arch Int Pharmacodyn Ther. 1990;306:170–81.PubMed Gyires K. Morphine inhibits the ethanol-induced gastric damage in rats. Arch Int Pharmacodyn Ther. 1990;306:170–81.PubMed
31.
go back to reference Kahrom M, Kahrom H. Perforation of peptic ulcer following abrupt cessation of long-term opiate use. Surg Today. 2010;40(9):836–9.PubMedCrossRef Kahrom M, Kahrom H. Perforation of peptic ulcer following abrupt cessation of long-term opiate use. Surg Today. 2010;40(9):836–9.PubMedCrossRef
32.
go back to reference Feldman M, Walsh JH, Taylor IL. Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans. Gastroenterology. 1980;79(2):294–8.PubMedCrossRef Feldman M, Walsh JH, Taylor IL. Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans. Gastroenterology. 1980;79(2):294–8.PubMedCrossRef
33.
go back to reference Anderson W, Molina E, Rentz J, Hirschowitz B. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone. J Pharmacol Exp Ther. 1982;222(3):617–24.PubMed Anderson W, Molina E, Rentz J, Hirschowitz B. Analysis of the 2-deoxy-D-glucose-induced vagal stimulation of gastric secretion and gastrin release in dogs using methionine-enkephalin, morphine and naloxone. J Pharmacol Exp Ther. 1982;222(3):617–24.PubMed
34.
go back to reference Morley JE, Levine AS, Silvis SE. Endogenous opiates and stress ulceration. Life Sci. 1982;31(7):693–9.PubMedCrossRef Morley JE, Levine AS, Silvis SE. Endogenous opiates and stress ulceration. Life Sci. 1982;31(7):693–9.PubMedCrossRef
35.
go back to reference Canfield SP, Spencer J. The action of morphine and naloxone on acid secretion by the rat isolated stomach. Eur J Pharmacol. 1981;71(1):135–8.PubMedCrossRef Canfield SP, Spencer J. The action of morphine and naloxone on acid secretion by the rat isolated stomach. Eur J Pharmacol. 1981;71(1):135–8.PubMedCrossRef
36.
go back to reference Lanas A, Serrano P, Bajador E, Fuentes J, Sáinz R. Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol. 2003;15(2):173–8.PubMedCrossRef Lanas A, Serrano P, Bajador E, Fuentes J, Sáinz R. Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol. 2003;15(2):173–8.PubMedCrossRef
37.
go back to reference Tørring ML, Riis A, Christensen S, Thomsen RW, Jepsen P, Søndergaard J, et al. Perforated peptic ulcer and short-term mortality among tramadol users. Br J Clin Pharmacol. 2008;65(4):565–72.PubMedCrossRef Tørring ML, Riis A, Christensen S, Thomsen RW, Jepsen P, Søndergaard J, et al. Perforated peptic ulcer and short-term mortality among tramadol users. Br J Clin Pharmacol. 2008;65(4):565–72.PubMedCrossRef
38.
go back to reference Turnage RH, Sarosi G, Cryer B, Spechler S, Peterson W, Feldman M. Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review. J Gastrointest Surg. 2003;7(5):606–26.PubMedCrossRef Turnage RH, Sarosi G, Cryer B, Spechler S, Peterson W, Feldman M. Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: a systematic review. J Gastrointest Surg. 2003;7(5):606–26.PubMedCrossRef
39.
go back to reference Kamada T, Hata J, Kusunoki H, Sugiu K, Tanimoto T, Mihara M, et al. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer. J Gastroenterol Hepatol. 2006;21(1 Pt 1):98–102.PubMedCrossRef Kamada T, Hata J, Kusunoki H, Sugiu K, Tanimoto T, Mihara M, et al. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer. J Gastroenterol Hepatol. 2006;21(1 Pt 1):98–102.PubMedCrossRef
40.
go back to reference Pecha RE, Prindiville T, Pecha BS, Camp R, Carroll M, Trudeau W. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers. Am J Gastroenterol. 1996;91(12):2523–7.PubMed Pecha RE, Prindiville T, Pecha BS, Camp R, Carroll M, Trudeau W. Association of cocaine and methamphetamine use with giant gastroduodenal ulcers. Am J Gastroenterol. 1996;91(12):2523–7.PubMed
42.
go back to reference Winans CS, Yoshii Y, Kobayashi S. Endoscopic diagnosis of multiple benign gastric ulcers. Gastrointest Endosc. 1972;19(2):63–6.PubMedCrossRef Winans CS, Yoshii Y, Kobayashi S. Endoscopic diagnosis of multiple benign gastric ulcers. Gastrointest Endosc. 1972;19(2):63–6.PubMedCrossRef
43.
45.
go back to reference Bakır T, Kazancıoglu S, Özoran Y. Evaluation of the gastric Ulcer patients in Blacksea Region of Turkey. Med J Islamic World Acad Sci. 1988;1(1):67–9. Bakır T, Kazancıoglu S, Özoran Y. Evaluation of the gastric Ulcer patients in Blacksea Region of Turkey. Med J Islamic World Acad Sci. 1988;1(1):67–9.
46.
go back to reference Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S, Amirabadizadeh AR, Zahedi MJ, et al. Lead poisoning among opium users in Iran: an emerging health hazard. Subst Abuse Treat Prev Policy. 2017;12(1):1–8.CrossRef Hayatbakhsh MM, Oghabian Z, Conlon E, Nakhaee S, Amirabadizadeh AR, Zahedi MJ, et al. Lead poisoning among opium users in Iran: an emerging health hazard. Subst Abuse Treat Prev Policy. 2017;12(1):1–8.CrossRef
47.
go back to reference Masoudi M, Zali MR, Mohammadalizadeh A-H Ehsanim, Aiassofi K, Aghazadeh R et al. Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. 2006. Masoudi M, Zali MR, Mohammadalizadeh A-H Ehsanim, Aiassofi K, Aghazadeh R et al. Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. 2006.
48.
go back to reference Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, et al. Determinants of Gastroesophageal Reflux Disease, including Hookah Smoking and Opium Use– A cross-sectional analysis of 50,000 individuals. PLoS ONE. 2014;9(2):e89256.PubMedPubMedCentralCrossRef Islami F, Nasseri-Moghaddam S, Pourshams A, Poustchi H, Semnani S, Kamangar F, et al. Determinants of Gastroesophageal Reflux Disease, including Hookah Smoking and Opium Use– A cross-sectional analysis of 50,000 individuals. PLoS ONE. 2014;9(2):e89256.PubMedPubMedCentralCrossRef
49.
go back to reference Darvishmoghadam S, Zahedi MJ, Abbasi MMH, Haghdoost AA, Khalilyzade M, Goughari EK. Review of clinical spectrum of gastroesophageal reflux disease in a general population; a study from south-east Iran. Middle East Journal of Digestive Diseases. 2016;8(4):310.PubMedPubMedCentralCrossRef Darvishmoghadam S, Zahedi MJ, Abbasi MMH, Haghdoost AA, Khalilyzade M, Goughari EK. Review of clinical spectrum of gastroesophageal reflux disease in a general population; a study from south-east Iran. Middle East Journal of Digestive Diseases. 2016;8(4):310.PubMedPubMedCentralCrossRef
Metadata
Title
Peptic ulcer characteristics in oral opium and non-opium user patients with upper gastrointestinal bleeding
Authors
Mohsen Masoodi
Mohammad Sabzikarian
Nikta Masoodi
Saeed Farhadi
Gholam Reza Rezamand
Seidamir Pasha Tabaeian
Atefeh Talebi
Farimah Fayyaz
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03137-7

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine